SCHEMBL3933529

SCHEMBL3933529

CCC(NC(C)C)C1(C(=O)O)CC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.31
MME P08473 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3936735 0.75 EPHX1 (0.38) CYP2C19ALDH1A1
SCHEMBL4555890 0.74 CTSK (0.46)
SCHEMBL10521828 0.73 FFAR3 (0.35)
SCHEMBL3140773 0.71
SCHEMBL3989590 0.70 EPHX1 (0.37) CYP2C19ALDH1A1
SCHEMBL4553549 0.69 FFAR3 (0.35)
SCHEMBL164042 0.69 FFAR3 (0.35)
SCHEMBL20168856 0.69 FFAR3 (0.35)
SCHEMBL3809509 0.68 FFAR3 (0.38) CYP2C19MMEALDH1A1
SCHEMBL4581131 0.68 FFAR3 (0.38) CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046793-A2 FUSED PYRIMIDO COMPOUNDS AstraZeneca AB (SE) 2009-04-15 EP disclosed
WO-2008003958-A2 FUSED PYRIMIDO COMPOUNDS ASTRAZENECA AB (SE) 2008-01-10 WO disclosed